Cooley

Todd Gluth

Deals
5
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 5 deals
Deals by year
Todd Gluth: deals by year0520252026 YTD: 5 M&A52026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Todd Gluth was named on, most recent first
Jun 2026 First Street –MSCIAcquisitionLegal adviser to First Street (target)Announced120.0Data & Analytics+1MSCI acquisition of First Street
May 2026 Vaccine Company –LillyAcquisitionLegal adviser to Vaccine Company (target)Announced1,550.0Biotech+1Lilly acquisition of Vaccine Company
May 2026 Candid Therapeutics –UCBAcquisitionLegal adviser to Candid Therapeutics (target)Announced2,200.0Biotech+1UCB acquisition of Candid Therapeutics
Mar 2026 PFF enterprise (B2B) business Pro Football FocusTeamworksAsset saleLegal adviser to Pro Football Focus (seller)Announced–Data & AnalyticsTeamworks acquisition of PFF enterprise (B2B) business
Feb 2026 35Pharma –GSKAcquisitionLegal adviser to 35Pharma (target)Announced950.0Biotech+1GSK acquisition of 35Pharma

Deals where Todd Gluth is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.